Eastman Chemical Company is grappling with a 59.4% projected drop in earnings, estimated at only $0.76 per share, leading to a strategic announcement of $175 million in cost reductions. Despite a price target raise from Citi analyst Patrick Cunningham to $75, the company's financial outlook remains shaky, with a troubling 26.63% decline in total shareholder returns over the past year. The stock has drawn mixed reactions, as RBC Capital's downgrade reflects ongoing demand weakness and anticipated revenue declines of 1.0% per year.
“Eastman Chemical Company · is included among · the 15 Best High Yield Stocks to Buy · true”
“Citi analyst Patrick Cunningham · raised his price target on Eastman Chemical Company · to $75 · from $72”
“Eastman Chemical (EMN) · is expected to post · quarterly earnings · $0.76 per share”
“Eastman Chemical (EMN) · represents a year-over-year change of · the earnings estimate · -59.4%”
“Eastman Chemical · carries a Zacks Rank of · #4 · Sell”
“Eastman Chemical · delivered a surprise of · -3.39% · last reported quarter's earnings”
“Eastman Chemical · has beaten consensus EPS estimates · two times · over the last four quarters”
“Eastman Chemical (EMN) · has a plan for · structural cost cuts · $175 million”
“Eastman Chemical · has a 90 day share price return of · share price return · 8.15%”
“Eastman Chemical · has a 1 year total shareholder return decline of · total shareholder return · 26.63%”
“Eastman Chemical · has a P/E ratio of · Price-to-Earnings · 10.8x”
“Eastman Chemical · is described as trading at good value versus · peers and the wider chemicals industry · average P/E levels are more than double EMN's 10.8x”
